NASDAQ CEO on corporate America under Trump
Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...
According to Nasdaq’s data, the U.S. saw 179 non-SPAC IPOs in 2024 – the most since 2021, and a 40% increase over 2023 (127). By value raised (ex SPACs), it was an even better year, with value raised ...
Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its ...
Skyline Builders Group Holding Limited (NASDAQ: SKBL), a Hong Kong-based public works contractor, launched its initial public ...
Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...
Shares surged through the $40 level as the stock gained another 20%. Nano Nuclear shares are now trading 75& higher in 2025 ...
Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.
Rashaun Williams, Atlanta Falcons limited partner and venture capitalist, joined "Closing Bell" on CNBC to discuss his investment strategy and his outlook on the IPO market as 2025 ...
Ribbon Acquisition Corp , a special purpose acquisition company (SPAC), has successfully completed its initial public offering (IPO), raising $52.2 million in total proceeds. The company, which trades ...
Axon Enterprise (NASDAQ: AXON) has been one of the most successful under-the-radar stock market investments of this century.
1don MSN
As a result, Renaissance expects a banner year for IPOs, with an estimated volume range of 155 to 195 IPOs in 2025 and $40 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback